HPLC in FDA Warning Letters

Recommendation

The Analytical Procedure Lifecycle

17/18 November 2026
Heidelberg, Germany

The Analytical Procedure Lifecycle
Enhanced Approach using AQbD Principles

On the Road to 30,000 Members

Let us become the World's Leading GMP/GDP Compliance Community in 2026

Let us become the World's Leading GMP/GDP Compliance Community in 2026

In the current compilation of Warning Letters issued between 2009 and 2011 we have summarised for you the key points regarding the use of high performance liquid chromatography (HPLC).

The inspection focuses can be summarised and compiled in the following 4 themes:

  • Raw Data / Protection of Electronic Records
  • Calibration / Qualification
  • Method Validation
  • System Suitability / Sequences

All these topics and further important aspects of a GMP/FDA compliant use of HPLC in the GMP laboratory will be covered in detail and discussed in ECA's Education Course "Maximising HPLC Productivity" from 18 - 20 April 2012 in Prague. This event will be a great opportunity for you to prepare your HPLC lab for the next FDA inspection.

Author:
Dr Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)

Conference Recommendations

The Analytical Procedure Lifecycle

Heidelberg, Germany
17/18 November 2026

The Analytical Procedure LifecycleEnhanced Approach using AQbD Principles

Quality Control of Starting Materials (APIs and Excipients) - Live Online Training


2/3 March 2027

Quality Control of Starting Materials (APIs and Excipients) - Live Online TrainingTesting and Sampling of Incoming Active Pharmaceutical Ingredients (APIs) and Excipients

GMP/FDA Compliance in Analytical Laboratories

Barcelona, Spain
9-11 March 2027

GMP/FDA Compliance in Analytical LaboratoriesHow to implement cGMP requirements in the everyday practice of quality control laboratories

Related GMP News

02.11.2026FDA Warning Letter: When Test Procedures Allow Retesting Until an Acceptable Result is Obtained

21.10.2026EMA Updates Information Page on Bioequivalence Guidelines

21.10.2026BP Publishes new Draft Texts

21.10.2026FDA Identifies Critical Deficiencies in Analytical Testing and CGMP Oversight

07.10.2026Analytical Quality Group Developments May through August 2026

07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus

Go back

NEWSLETTER

Stay informed with the GMP Newsletters from ECA

GMP Newsletter

The ECA offers various free of charge GMP newsletters for which you can subscribe to according to your needs.

To subscribe, please click here.